AI Science Tracker
EN

Electrocardiogram-based Artificial Intelligence to Predict Incident Heart Failure With Preserved vs Reduced Ejection Fraction.

Affiliation not stated in the reviewed material · 1 Nov 2026 · medicine

Discovery

Electrocardiogram-based Artificial Intelligence to Predict Incident Heart Failure With Preserved vs Reduced Ejection Fraction.

Source check: Source checked. Not independent scientific confirmation.

Finding: Primary article reports ECG2HF-Subtype developed in 98,190 MGH individuals and tested in MGH/BWH/BIDMC sets; 10-year incident HFrEF/HFpEF discrimination is compared with age/sex and PREVENT-HF logistic model. Retrospective risk prediction only. The result is reported in the Journal of Cardiac Failure. Affiliation was not stated in the reviewed material. It does not establish generalization beyond the reported setting or prospective real-world benefit.

Technology: Primary article reports ECG2HF-Subtype developed in 98,190 MGH individuals and tested in MGH/BWH/BIDMC sets

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Primary article reports ECG2HF-Subtype developed in 98,190 MGH individuals and tested in MGH/BWH/BIDMC sets
Test and result
Primary article reports ECG2HF-Subtype developed in 98,190 MGH individuals and tested in MGH/BWH/BIDMC sets; 10-year incident HFrEF/HFpEF discrimination is compared with age/sex and PREVENT-HF logistic model. Retrospective risk prediction only.
Limitation / still unknown
Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13775186/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.